Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH mee

[News]

Novartis will highlight more than 140 presentations on key data from its extensive oncology portfolio at the leading year-end scientific meetings devoted to hematology and breast cancer, demonstrating continued innovation in research and development efforts to advance the care of patients with cancer and rare diseases.

More... (http://www.news-medical.net/news/20121130/Novartis-to-highlight-key-data-from-extensive-oncology-portfolio-at-SABCS-and-ASH-meeting.aspx)